Results 231 to 240 of about 87,437 (368)

An Isoform-Specific RUNX1C-BTG2 Axis Governs AML Quiescence and Chemoresistance. [PDF]

Blood Cancer Discov
Han C, Zhang Z, Crosse EI, Sajedi S, Lu B, Wang X, Karma S, Kostich M, Rajendran SH, Udy DB, Chen S, Arnuk A, Lawal AE, Koenig KR, McKenna M, Reville PK, Abbas HA, Abdel-Wahab O, Miura P, Bradley RK, Wang E.   +20 more
europepmc   +1 more source

A phase 2 study incorporating sorafenib into the chemotherapy for older adults with FLT3-mutated acute myeloid leukemia: CALGB 11001 [PDF]

, 2017
Uy, Geoffrey L., Westervelt, Peter
core   +1 more source

Insights into the clinical, platelet and genetic landscape of inherited thrombocytopenia with malignancy risk

British Journal of Haematology, Volume 207, Issue 4, Page 1565-1577, October 2025.
Inherited thrombocytopenia (IT) caused by germline variants in RUNX1, ETV6 or ANKRD26 carries a high risk of developing haematological malignancy. This study examined the clinical, platelet and molecular characteristics of 66 patients with these conditions, who carried 24 distinct genetic variants in the corresponding genes.
Ana Marín‐Quílez, Ana Sánchez‐Fuentes, Ana Zamora‐Cánovas, Pedro Luis Gómez‐González, Lorena Diaz‐Ajenjo, Rocío Benito, Agustín Rodríguez‐Alén, Teresa Sevivas, Thais Murciano, Laura Murillo, Nora V. Butta, Nuria Revilla, Rosa Campos, Paola Escribano, Jordi Esteve, Nuria Fernández‐Mosteirin, Francisca Ferrer‐Marín, Laura Hernández, Jorge Huerta‐Aragonés, Antonio León, Mónica López‐Duarte, Eugenia López, Mónica Martín‐Salces, Meritxell Nomdedeu, Raquel Oña, Irene Peláez‐Pleguezuelos, Fernando Ramos, Elena Sebastián, Claudia Serrano, Cristina Sierra‐Aisa, Rosa Vidal‐Laso, José Ramón González‐Porras, María Luisa Lozano, José María Bastida, José Rivera   +34 more
wiley   +1 more source

The synergistic effect of 2-deoxy-D-glucose and cytarabine on mitochondria of stem-like cells derived from KG1-a. [PDF]

Leuk Res Rep
Rezaei S, Mohammadzadeh-Vardin M, Amirshahrokhi K, Amani M.   +3 more
europepmc   +1 more source

Methotrexate and cytarabine inhibit progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene [PDF]

, 2004
Tülin Budak-Alpdoǧan, Önder Alpdoğan, Debabrata Banerjee, Eunice S. Wang, Malcolm A.S. Moore, Joseph R. Bertino   +5 more
openalex   +1 more source

CD123‐targeting immunotherapeutic approaches in acute myeloid leukaemia

British Journal of Haematology, Volume 207, Issue 4, Page 1178-1191, October 2025.
Summary Treatment of relapsed or refractory acute myeloid leukaemia (AML) has remained a significant challenge, with limited available targeted immunotherapies. CD123, or the interleukin‐3 (IL‐3) receptor, has long been known as a potential target expressed on AML blasts, and a range of different approaches to targeting CD123 have been trialled with ...
Alexandra Dreyzin, Noa G. Holtzman, Challice L. Bonifant   +2 more
wiley   +1 more source

Emphysematous Gastritis in the Setting of Stage Four Colon Cancer After Radiation Therapy and Ongoing Chemotherapy: A Case Report. [PDF]

Cureus
Johnson RW, Obeng K, DePaz H, Gilani M, Saeed K.   +4 more
europepmc   +1 more source

Cardiotoxicity in patients with acute myeloid leukaemia following anthracycline‐containing chemotherapy: A population‐based matched cohort study

British Journal of Haematology, Volume 207, Issue 4, Page 1416-1424, October 2025.
Summary Anthracycline‐containing chemotherapy is associated with cardiovascular diseases (CVDs). While knowledge regarding the extent of cardiotoxicity in adult patients with acute myeloid leukaemia (AML) is sparse, anthracyclines remain a key component in the treatment.
Rikke Hedegaard Jensen, Christian Teglgaard, Jonas Faartoft Jensen, Joachim Baech, Claus Werenberg Marcher, Anne Stidsholt Roug, Andreas Due Ørskov, Claudia Schöllkopf, Daniel Tuyet Kristensen, Rasmus Froberg Brøndum, Marianne Tang Severinsen   +10 more
wiley   +1 more source

Real-world management of blastic plasmacytoid dendritic cell neoplasm at an academic center with a broad regional referral base. [PDF]

Leuk Res Rep
Krah NM, Hoeg R, Shami PJ, Elf SE, Lee LE, Pemmaraju N, Patel AB.   +6 more
europepmc   +1 more source

Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD–positive leukemic cells [PDF]

, 2004
Kevin Yee, Marcus M. Schittenhelm, Anne-Marie O'Farrell, Ajia Town, Laura McGreevey, Troy Bainbridge, Julie M. Cherrington, Michael C. Heinrich   +7 more
openalex   +1 more source